OBJECTIVE: To examine the frequency with which quality of life and treatment limitation were discussed in formal family meetings for long-stay intensive care unit patients with high risk for mortality and morbidity. DESIGN: Descriptive observational study. SETTING: Five intensive care units. PATIENTS: One hundred sixteen family surrogate decisionmakers of long-stay intensive care unit patients who participated in an intensive communication system that aimed to provide weekly meetings with family decisionmakers. The structure of each meeting was to address medical update, patient preferences, treatment plan, and milestones for evaluating the treatment plan. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We audiotaped initial family meetings for 116 family decisionmakers for a total of 180 meetings. On average, meetings were 24 mins long with a majority of time being devoted to nonemotional speech and little (12%) spent discussing patient preferences. Quality of life was discussed in 45% and treatment limitation in 23% of all meetings. Quality-of-life discussions were more likely to occur when patients were admitted to a medical intensive care unit (odds ratio [OR] 5.9; p = .005), have a family decisionmaker who is a spouse (OR 9.4; p = .0001), were older (OR 1.04; p = 01), have a shorter length of stay (OR 0.93; p = .001), and have a family decisionmaker who was a spouse (OR 5.1; p = .002). For those with a treatment limitation discussion, 67% had a do-not-resuscitate order, 40% were admitted to a medical intensive care unit, 56% had a family decisionmaker who had been their caregiver, and 48% of their family decisionmakers were their children. CONCLUSIONS: To guide discussion with families of the subset of intensive care unit patients with high risk of mortality and long-term morbidity, quality of life was not consistently addressed. Continued efforts to assist clinicians in routinely including discussions of quality-of-life outcomes is needed.
OBJECTIVE: To examine the frequency with which quality of life and treatment limitation were discussed in formal family meetings for long-stay intensive care unit patients with high risk for mortality and morbidity. DESIGN: Descriptive observational study. SETTING: Five intensive care units. PATIENTS: One hundred sixteen family surrogate decisionmakers of long-stay intensive care unit patients who participated in an intensive communication system that aimed to provide weekly meetings with family decisionmakers. The structure of each meeting was to address medical update, patient preferences, treatment plan, and milestones for evaluating the treatment plan. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We audiotaped initial family meetings for 116 family decisionmakers for a total of 180 meetings. On average, meetings were 24 mins long with a majority of time being devoted to nonemotional speech and little (12%) spent discussing patient preferences. Quality of life was discussed in 45% and treatment limitation in 23% of all meetings. Quality-of-life discussions were more likely to occur when patients were admitted to a medical intensive care unit (odds ratio [OR] 5.9; p = .005), have a family decisionmaker who is a spouse (OR 9.4; p = .0001), were older (OR 1.04; p = 01), have a shorter length of stay (OR 0.93; p = .001), and have a family decisionmaker who was a spouse (OR 5.1; p = .002). For those with a treatment limitation discussion, 67% had a do-not-resuscitate order, 40% were admitted to a medical intensive care unit, 56% had a family decisionmaker who had been their caregiver, and 48% of their family decisionmakers were their children. CONCLUSIONS: To guide discussion with families of the subset of intensive care unit patients with high risk of mortality and long-term morbidity, quality of life was not consistently addressed. Continued efforts to assist clinicians in routinely including discussions of quality-of-life outcomes is needed.
Authors: Barbara J Daly; Sara L Douglas; Elizabeth O'Toole; Nahida H Gordon; Rana Hejal; Joel Peerless; James Rowbottom; Allan Garland; Craig Lilly; Clareen Wiencek; Ronald Hickman Journal: Chest Date: 2010-06-24 Impact factor: 9.410
Authors: Lawrence J Schneiderman; Todd Gilmer; Holly D Teetzel; Daniel O Dugan; Jeffrey Blustein; Ronald Cranford; Kathleen B Briggs; Glen I Komatsu; Paula Goodman-Crews; Felicia Cohn; Ernlé W D Young Journal: JAMA Date: 2003-09-03 Impact factor: 56.272
Authors: Leslie P Scheunemann; Natalie C Ernecoff; Praewpannarai Buddadhumaruk; Shannon S Carson; Catherine L Hough; J Randall Curtis; Wendy G Anderson; Jay Steingrub; Bernard Lo; Michael Matthay; Robert M Arnold; Douglas B White Journal: JAMA Intern Med Date: 2019-05-01 Impact factor: 21.873
Authors: Leslie P Scheunemann; Thomas V Cunningham; Robert M Arnold; Praewpannarai Buddadhumaruk; Douglas B White Journal: Crit Care Med Date: 2015-04 Impact factor: 7.598
Authors: Martha A Abshire; Xintong Li; Pragyashree Sharma Basyal; Melissa L Teply; Arun L Singh; Margaret M Hayes; Alison E Turnbull Journal: PLoS One Date: 2020-05-29 Impact factor: 3.240